MEDSCI (02415) Subsidiary Wins Major Real-World Research Project Contract for "Gout Smart Management Plan" from Chinese Pharmaceutical Company

Stock News

Sep 25

MEDSCI (02415) announced that its subsidiary, Shanghai MedSci Medical Technology Co., Ltd., has recently won the bid for a major real-world research project from a Chinese pharmaceutical company. The project aims to "systematically evaluate the effectiveness and safety of IL-1β monoclonal antibody treatment for patients with acute and intermittent gout through a combination of prospective and retrospective observational studies." The contract value is approximately RMB 21 million.

The Group leverages its internet doctor platform accumulated over more than ten years of experience, applying big data and artificial intelligence technology to connect doctors, patients, and pharmaceutical and medical device companies, providing digital solutions to empower the medical ecosystem and improve medical quality.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1105375290"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1105375290\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1105375290?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-25 19:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1105375290","market":"fut","top_or_hot":-1,"title":"MEDSCI (02415) Subsidiary Wins Major Real-World Research Project Contract for \"Gout Smart Management Plan\" from Chinese Pharmaceutical Company","media":"Stock News","content":"<p>MEDSCI (02415) announced that its subsidiary, Shanghai MedSci Medical Technology Co., Ltd., has recently won the bid for a major real-world research project from a Chinese pharmaceutical company. The project aims to \"systematically evaluate the effectiveness and safety of IL-1β monoclonal antibody treatment for patients with acute and intermittent gout through a combination of prospective and retrospective observational studies.\" The contract value is approximately RMB 21 million.</p>\n<p>The Group leverages its internet doctor platform accumulated over more than ten years of experience, applying big data and artificial intelligence technology to connect doctors, patients, and pharmaceutical and medical device companies, providing digital solutions to empower the medical ecosystem and improve medical quality.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MEDSCI (02415) Subsidiary Wins Major Real-World Research Project Contract for \"Gout Smart Management Plan\" from Chinese Pharmaceutical Company</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMEDSCI (02415) Subsidiary Wins Major Real-World Research Project Contract for \"Gout Smart Management Plan\" from Chinese Pharmaceutical Company\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-09-25 19:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>MEDSCI (02415) announced that its subsidiary, Shanghai MedSci Medical Technology Co., Ltd., has recently won the bid for a major real-world research project from a Chinese pharmaceutical company. The project aims to \"systematically evaluate the effectiveness and safety of IL-1β monoclonal antibody treatment for patients with acute and intermittent gout through a combination of prospective and retrospective observational studies.\" The contract value is approximately RMB 21 million.</p>\n<p>The Group leverages its internet doctor platform accumulated over more than ten years of experience, applying big data and artificial intelligence technology to connect doctors, patients, and pharmaceutical and medical device companies, providing digital solutions to empower the medical ecosystem and improve medical quality.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02415","symbol_name":"梅斯健康","start_time":0,"source_url":"","article_id":"1105375290","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1105375290","pubTimestamp":1758800083,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"MEDSCI (02415) announced that its subsidiary, Shanghai MedSci Medical Technology Co., Ltd., has recently won the bid for a major real-world research project from a Chinese pharmaceutical company. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02415":"梅斯健康","BK1189":"医疗保健技术"},"translate_title":"MEDSCI(02415)附属获中国药企“痛风智慧管理计划”重大真实世界研究项目合约","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02415":1},"content_text":"MEDSCI (02415) announced that its subsidiary, Shanghai MedSci Medical Technology Co., Ltd., has recently won the bid for a major real-world research project from a Chinese pharmaceutical company. The project aims to \"systematically evaluate the effectiveness and safety of IL-1β monoclonal antibody treatment for patients with acute and intermittent gout through a combination of prospective and retrospective observational studies.\" The contract value is approximately RMB 21 million.\nThe Group leverages its internet doctor platform accumulated over more than ten years of experience, applying big data and artificial intelligence technology to connect doctors, patients, and pharmaceutical and medical device companies, providing digital solutions to empower the medical ecosystem and improve medical quality.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}